sanofi-logo.jpg
Plerixafor, 10 years after approval: Time to abandon chemotherapy for stem cell mobilization?

Sanofi Genzyme supported Industry Lunch Symposium (Hall A)

Saturday, October 26

13:15–14:15

Chair: Nicolaus Kröger (Hamburg, Germany)
 
Welcome and introduction
Nicolaus Kröger (Hamburg, Germany)
​
Chemotherapy-based approaches
Nina Worel (Wien, Austria)
​
Cytokine-based approaches (including paediatric indications)
Mohamad Mohty (Paris, France)
​
Panel discussion